Preparation and Characterization of Folate-Targeted Fe<sub>3</sub>O<sub>4</sub> Nanoparticle Codelivering Cisplatin and TFPI-2 Plasmid DNA for Nasopharyngeal Carcinoma Therapy

<div>Cytotoxicity analyses on NP-69 cells.</div>

Journal of Nanomaterials

fig7

Figure 7

Figure 7: Preparation and Characterization of Folate-Targeted Fe<sub>3</sub>O<sub>4</sub> Nanoparticle Codelivering Cisplatin and TFPI-2 Plasmid DNA for Nasopharyngeal Carcinoma Therapy 

Figure 7 | Preparation and Characterization of Folate-Targeted Fe3O4 Nanoparticle Codelivering Cisplatin and TFPI-2 Plasmid DNA for Nasopharyngeal Carcinoma Therapy 